Stockscreener 앱 받기
16.02
0.12%
0.02
Latigo Biotherapeutics, Inc. Common Stock (LTGO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 |
| 기간 | 3개월 |
| Operating Expenses | |
| Operating Income/Loss | |
| Nonoperating Income/Loss | |
| Income Tax Expense/Benefit | |
Net Income/Loss
|
|
| Basic Average Shares | |
| Diluted Average Shares | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share |
5.11%
자본화:
|
볼륨(24시간):